Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Incyte
Incyte
Concert rethinks R&D plans after loss in Incyte patent case
Fierce Biotech
Fri, 01/12/18 - 06:40 pm
Concert Pharmaceuticals
Incyte
patents
R&D
CTP-543
JPM18: Incyte and Syros to collaborate in cancer R&D
Biopharma Dive
Wed, 01/10/18 - 06:57 pm
Incyte
Syros Pharmaceuticals
cancer
R&D
JPMHC 2018
5 Biggest New Drugs of 2018
Motley Fool
Sun, 01/7/18 - 12:35 pm
Gilead Sciences
Bictegravir/F/TAF
Novo Nordisk
semaglutide
Ozempic
Incyte
epacadostat
AbbVie
Rova-T
Celgene
ozanimod
Why These 3 Biotech Stocks Could Outperform Their Peers In 2018
Investors Business Daily
Sat, 01/6/18 - 12:32 pm
biotech
Puma Biotechnology
Incyte
Clovis Oncology
3 Promising Cancer Immunotherapies to Watch in 2018
Yahoo/Motley Fool
Fri, 12/22/17 - 09:46 am
cancer
immuno-oncology
Incyte
epacadostat
Bristol-Myers Squibb
relatlimab
Nektar
NKTR-214
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
drug launches
Bictegravir/F/TAF
Gilead Sciences
semaglutide
Novo Nordisk
epacadostat
Incyte
Rova-T
AbbVie
ozanimod
Celgene
apalutamide
JNJ
Elagolix
AVXS-101
AveXis
lanadelumab
Shire
Epidiolex
GW Pharma
8 Takeout targets to watch in 2018
BioPharma Dive
Sat, 12/16/17 - 08:41 am
M&A
Allergan
Alnylam
Biomarin
Bristol-Myers Squibb
Incyte
Madrigal Pharmaceuticals
Spark Therapeutics
Sucampo
Bristol-Myers offers a positive snapshot on early data for an IDO1 rival to Incyte
Endpoints
Fri, 11/10/17 - 11:35 am
Bristol-Myers Squibb
IDO1
BMS-986205
Incyte
bladder cancer
cervical cancer
AstraZeneca plans new pivotal lung cancer trial with Incyte
Yahoo/Reuters
Tue, 10/31/17 - 10:04 am
AstraZeneca
Incyte
clinical trials
Imfinzi
epacadostat
lung cancer
Incyte grabs a new PD-1 checkpoint drug in $900M deal with MacroGenics
Endpoints
Wed, 10/25/17 - 09:44 am
Incyte
PD-1 inhibitors
Macrogenics
MGA012
That $1.25B Bristol-Myers IDO1 drug? Incyte claims a former staffer stole it
Endpoints
Sun, 10/15/17 - 01:16 pm
Bristol-Myers Squibb
IDO1
Incyte
Flexus
Biotech Firm Incyte Finds The Right Chemistry For Success
Forbes
Tue, 10/10/17 - 10:25 am
Incyte
biotech
Jakafi
3 Monster Biotech Stocks in the Making
Motley Fool
Sun, 09/24/17 - 10:24 am
biotech
Exelixis
Incyte
Vertex Pharmaceuticals
Incyte’s good week continues with an encouraging update on IDO1 star epacadostat
Endpoints
Thu, 08/31/17 - 10:07 pm
Incyte
IDO1
epacadostat
Keytruda
Merck
Incyte, Merck build case for skin cancer combo
BioPharma Dive
Thu, 08/31/17 - 11:42 am
Incyte
Merck
Keytruda
advanced melanoma
3 Most Promising Cancer Drugs in Late-Stage Development
Motley Fool
Tue, 08/22/17 - 10:04 am
Eli Lilly
abemaciclib
advanced breast cancer
Incyte
epacadostat
Imbruvica
JNJ
prostate cancer
The sector’s most valuable unpartnered assets – up for grabs or on the shelf?
EP Vantage
Tue, 08/22/17 - 09:55 am
R&D
Kite Pharma
Incyte
Portola Pharmaceuticals
DBV Technologies
Axovant
AveXis
Tesaro's rumored buyers aren't biting. Should Gilead go for Incyte instead?
Fierce Pharma
Sat, 07/15/17 - 11:14 am
Tesaro
Gilead Sciences
Incyte
M&A
Pining for a megadeal, an analyst kicks the tires for another Gilead M&A test drive
Endpoints
Fri, 07/14/17 - 11:28 am
M&A
Gilead Sciences
Incyte
Vertex Pharmaceuticals
John Milligan
3 Biotech Stocks That Could Become M&A Targets
Motley Fool
Sat, 06/17/17 - 03:05 pm
biotech
M&A
Mallinckrodt
Tesaro
Incyte
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »